Skip to content

HyperVue™ Imaging System

by Spectrawave, Inc.

510(k) K230691

HyperVue Imaging System is a medical device (FDA Class II; FDA product code NQQ, System, Imaging, Optical Coherence Tomography (Oct)) made by Spectrawave, Inc., cleared under FDA 510(k) K230691 on 7 Jun 2023, active as of 26 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 26 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 26 Oct 2026.

Regulatory status

as of registry sync 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK230691 Date7 Jun 2023ClearedStatusActive

Official records

From the FDA record

Received by the FDA
13 Mar 2023
FDA decision
7 Jun 2023 (Substantially Equivalent)
FDA review time
86 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K230691 (openFDA), as read on 26 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
NQQ
Device class
Class II
Regulation
21 CFR Part 892.1560
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code NQQ (System, Imaging, Optical Coherence Tomography (Oct)).

Other devices from Spectrawave, Inc.

See all devices from Spectrawave, Inc. →